Illinois Department of Public Health (IDPH) launched a new effort on Tuesday to eliminate viral hepatitis in Illinois. The Illinois Hepatitis Coalition held its inaugural meeting, bringing together key stakeholders – including clinicians, academic researchers, and community partners – with the goal of formulating an equity-driven strategic plan to end the viral hepatitis epidemic in the state. The work of the coalition is funded through a $1.5 million federal grant. Recent data indicates that cases of hepatitis B and C have continued to rise in Illinois. In 2020, the data showed a total of 388 confirmed cases of hepatitis B and 2,873 confirmed cases of hepatitis C, however many people with these diseases remain undiagnosed. According to the 2020 CDC National Notifiable Diseases Surveillance system, there was an increase in the Hepatitis C rate in Illinois from 1.2/per 100,000 population in 2019 to 1.6/per 100,000 in 2020, which was above the U.S average. Hepatitis B rates in Illinois have fluctuated over the last five years but remain below the national average in 2020. Viral hepatitis is the leading cause of liver cancer and the most common reason for liver transplantation. An estimated 4.4 million Americans are living with chronic hepatitis. The disease affects the entire population, but certain populations are at higher risk of certain types of hepatitis, including those who engage in intravenous drug use or children born to such individuals.